{"id":474881,"date":"2026-06-03T23:02:11","date_gmt":"2026-06-03T23:02:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/474881\/"},"modified":"2026-06-03T23:02:11","modified_gmt":"2026-06-03T23:02:11","slug":"transformative-car-t-therapy-allows-three-people-to-receive-kidney-transplants","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/474881\/","title":{"rendered":"\u2018Transformative\u2019 CAR-T therapy allows three people to receive kidney transplants"},"content":{"rendered":"<p> <img decoding=\"async\" class=\"figure__image\" alt=\"Surgeons in blue sterile gowns, masks and caps perform a kidney removal surgery on a patient in a hospital operating room, working under large overhead surgical lights while medical equipment, monitors and IV bags surround the operating table\" loading=\"lazy\" src=\"https:\/\/www.newsbeep.com\/il\/wp-content\/uploads\/2026\/06\/d41586-026-01761-9_52496674.jpg\"\/><\/p>\n<p class=\"figure__caption u-sans-serif\">People whose kidneys stop functioning properly can wait years to receive a donor organ.Credit: Burger\/Phanie\/Science Photo Library<\/p>\n<p>A single dose of engineered immune cells has helped two men and one woman to receive life-saving kidney transplants. The trio are part of a group of patients who have \u2018highly sensitized\u2019 immune systems \u2014 meaning that they are often not eligible to receive transplants because their bodies usually reject the donated organs.<\/p>\n<p>\u201cThese people die on the waiting list \u2014 they never get a kidney,\u201d says Allan Kirk, a kidney transplant surgeon at Duke University Hospital in Durham, North Carolina, who was not involved in their care. Using these immune cells to make transplants possible \u201ccould be a real game changer\u201d, Kirk says.<\/p>\n<p>More than a year after receiving the cells, the three people are now living with new kidneys and without notable side effects. Their success stories were published today in the New England Journal of Medicine in two reports by independent research teams<a href=\"#ref-CR1\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">1<\/a>,<a href=\"#ref-CR2\" data-track=\"click\" data-action=\"anchor-link\" data-track-label=\"go to reference\" data-track-category=\"references\">2<\/a>.<\/p>\n<p>Few options remaining<\/p>\n<p>When a person\u2019s kidneys stop functioning, or go into \u2018failure\u2019, dialysis and transplants are the only available treatments. Dialysis, which uses a machine to clean a person\u2019s blood, is time-intensive, taking up to several hours a day, usually three days a week. It consumes people\u2019s lives and leaves them physically exhausted, says Ali Naji, a transplant surgeon at the University of Pennsylvania in Philadelphia and an author of one of the reports.<\/p>\n<p><a href=\"https:\/\/www.nature.com\/articles\/d41586-026-01108-4\" class=\"u-link-inherit\" data-track=\"click\" data-track-label=\"recommended article\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" class=\"recommended__image\" alt=\"\" src=\"https:\/\/www.newsbeep.com\/il\/wp-content\/uploads\/2026\/06\/d41586-026-01761-9_52272770.jpg\"\/><\/p>\n<p class=\"recommended__title u-serif\">One woman, three autoimmune diseases: CAR-T therapy vanquishes ultra-rare disease trio<\/p>\n<p><\/a><\/p>\n<p>Transplants offer the possibility of a relatively normal life, but for the more than 91,000 people in the United States who are on waiting lists for a kidney transplant, an estimated 5\u201310% of them have highly sensitized immune systems. Their bodies produce high levels of antibodies that attack foreign biomolecules and tissues, such as those found in a donor organ.<\/p>\n<p>One woman with this condition came to the hospital \u201cagain and again\u201d \u2014 nine times in all \u2014 accompanied by potential donors who turned out not to be an immunological fit, says Eva Schrezenmeier, a nephrologist at Charit\u00e9 \u2014 University Medicine Berlin and an author of one of the studies. The woman was in her 30s and had previously received a kidney transplant that failed after a decade. Without working kidneys, she soon developed high blood pressure, which then led to heart failure. The dialysis she was receiving drained her energy, and she was no longer able to hold down a job. \u201cShe was very desperate,\u201d Schrezenmeier says.<\/p>\n<p>Engineered immune cells called <a href=\"https:\/\/www.nature.com\/articles\/d41586-026-00358-6\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-026-00358-6\" data-track-category=\"body text link\" rel=\"nofollow noopener\" target=\"_blank\">chimeric antigen receptor (CAR) T cells<\/a> offered a chance to improve and extend her life. They have been approved by regulatory agencies to treat a variety of blood cancers and have been <a href=\"https:\/\/www.nature.com\/articles\/d41586-025-03885-w\" data-track=\"click\" data-label=\"https:\/\/www.nature.com\/articles\/d41586-025-03885-w\" data-track-category=\"body text link\" rel=\"nofollow noopener\" target=\"_blank\">trialled for some autoimmune conditions<\/a>. Researchers now wanted to test whether these cells could suppress the high antibody levels that prevent people with highly sensitized immune systems from receiving transplants.<\/p>\n<p>Success stories<\/p>\n<p>CAR T cells are made by extracting and isolating a person\u2019s T cells \u2014 a type of immune cell \u2014 and then engineering them to attack other cells that produce a target protein. In the woman\u2019s case, cells in her body expressing a protein called CD19 were pumping out the trouble-making antibodies that prevented her from getting a new kidney.<\/p>\n","protected":false},"excerpt":{"rendered":"People whose kidneys stop functioning properly can wait years to receive a donor organ.Credit: Burger\/Phanie\/Science Photo Library A&hellip;\n","protected":false},"author":2,"featured_media":474882,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[114,4068,85,10922,46,1717,4069,141],"class_list":["post-474881","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-business","tag-humanities-and-social-sciences","tag-il","tag-immunology","tag-israel","tag-medical-research","tag-multidisciplinary","tag-science"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/474881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=474881"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/474881\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/474882"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=474881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=474881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=474881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}